Loading…

Development and validation of a nomogram for predicting internal mammary sentinel node metastasis in breast cancer patients

Internal mammary nodes are important in breast cancer prognosis, but their diagnosis is often missed in clinical practice, leading to inaccurate staging and treatment. We developed a validated nomogram to predict the presence of internal mammary sentinel nodes (IMSN) metastasis. A total of 864 seque...

Full description

Saved in:
Bibliographic Details
Published in:European journal of surgical oncology 2023-10, Vol.49 (10), p.107040-107040, Article 107040
Main Authors: Qiu, Peng-Fei, Lv, Qing, Zhao, Wen-He, Huang, Yuan-Xi, Zhu, Shi-Guang, Zhong, Hong, Yang, Guang-Lun, Bell, Steven, Wang, Li-Yang, Xu, Ying-Ying, Sun, Xiao, Chen, Yu-Guang, Ding, Qiang, Wang, Yong-Sheng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Internal mammary nodes are important in breast cancer prognosis, but their diagnosis is often missed in clinical practice, leading to inaccurate staging and treatment. We developed a validated nomogram to predict the presence of internal mammary sentinel nodes (IMSN) metastasis. A total of 864 sequential IMSN biopsy procedures from a prospective studies database of 1505 cases were used for model development and validation. Multivariable logistic regression was performed on 519 sequential IMSN biopsy procedures from multi-center data between August 2018 and July 2022 to predict the presence of IMSN metastasis. A nomogram was developed based on the logistic regression model and subsequently applied to 345 sequential IMSN biopsy procedures from single-center data between November 2011 and July 2018. The model's discrimination was assessed using the area under the receiver operating characteristic curve. The overall frequency of IMSN metastasis was 17.0% in our study. A predictive model for IMSN metastasis was constructed using tumor size, tumor location, lymphovascular invasion, the number of positive axillary nodes (P 
ISSN:0748-7983
1532-2157
DOI:10.1016/j.ejso.2023.107040